Syneos Health_rgb_r.jpg
Syneos Health Showcases Evolved Deployment Solutions at Future Pharma in Boston
September 09, 2019 07:30 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today will showcase Syneos Health Deployment...
Syneos Health_rgb_tm.png
Syneos Health to Present at the 2019 Baird Global Healthcare Conference
August 13, 2019 08:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health_rgb_tm.png
Syneos Health Reports Second Quarter 2019 Results
August 06, 2019 06:14 ET | Syneos Health, Inc.
Highlights GAAP revenue of $1,166.8 million for the three months ended June 30, 2019, representing growth of 8.8% compared to the same period in 2018.Adjusted revenue of $1,168.4 million for the...
Syneos Health_rgb_tm.png
Syneos Health CEO Alistair Macdonald Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine
August 01, 2019 10:45 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that CEO Alistair Macdonald has...
Syneos Health_rgb_tm.png
Syneos Health Schedules Second Quarter 2019 Earnings Call for Tuesday, August 6, 2019
July 08, 2019 08:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., July 08, 2019 (GLOBE NEWSWIRE) -- Syneos HealthTM (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization...
Syneos Health_rgb_tm.png
Syneos Health Introduces FSP 360 – Next Evolution Model Provides Customers Broadest Range of Functional Service Provider Solutions
June 24, 2019 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today introduced FSP 360, an evolved  FSP model...
Syneos Health_rgb_tm.png
Syneos Health Appoints Patrick Nealon, Head of Oncology
May 31, 2019 10:49 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 31, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Patrick...
Syneos Health_rgb_tm.png
Syneos Health to Present at Upcoming Investor Conferences
May 21, 2019 17:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization)...
Syneos Health_rgb_tm.png
Syneos Health Leaders Honored by the Healthcare Businesswomen’s Association for Visionary Healthcare Expertise
May 09, 2019 12:18 ET | Syneos Health
MORRISVILLE, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Tara Fitzgerald, President,...
Syneos Health_rgb_tm.png
Syneos Health Reports First Quarter 2019 Results
May 09, 2019 06:19 ET | Syneos Health
Highlights GAAP revenue of $1.12 billion for the three months ended March 31, 2019.Net new business awards of $5.52 billion for the trailing twelve months (TTM) ended March 31, 2019, representing a...